AG
VCYT icon

AmeriFlex Group’s Veracyte VCYT Stock Holding History

AmeriFlex Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225 Hold
7
– – ﹤0.01% 1065
2025
Q4 		$295 Sell
7
-7
-50% -$282 ﹤0.01% 1083
2025
Q3 		$481 Buy
+14
New +$402 ﹤0.01% 1042

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AmeriFlex Group's VCYT Position: Q1 2026 in Review

AmeriFlex Group held its Veracyte (VCYT) position steady in Q1 2026 at 7 shares worth $225. The position accounts for ﹤0.01% of the portfolio, ranked #1065.

AmeriFlex Group first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $481 in Q3 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • AmeriFlex Group held 7 shares of Veracyte worth $225 as of Q1 2026.
  • AmeriFlex Group left its Veracyte share count unchanged in Q1 2026.
  • Veracyte made up ﹤0.01% of AmeriFlex Group's portfolio in Q1 2026, its #1065 holding.
  • AmeriFlex Group first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • AmeriFlex Group's Veracyte position peaked at $481 in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on AmeriFlex Group's 13F filing for Q1 2026, filed 15 May 2026.